RT Journal Article
SR Electronic
T1 A Multidirectional Two-tube Method for Chemical Pleurodesis could improve distribution of the Sclerosing Agent within the Pleural Cavity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.06.21254972
DO 10.1101/2021.04.06.21254972
A1 Eoin Campion
A1 Saad I. Mallah
A1 Maimoona Azhar
A1 Dara O’Keeffe
A1 Aamir Hameed
YR 2021
UL http://medrxiv.org/content/early/2021/04/09/2021.04.06.21254972.abstract
AB Introduction Malignant pleural effusion (MPE) affects approximately 200,000 people in the United States per annum. Chemical pleurodesis is a recommended first line treatment in the management of MPE, however, success rates as low as 43% has been reported. A bedside chemical pleurodesis can cost up to $11,224 and an estimated inpatient annual expenditure of more than $5 billion in the US alone. This study aims to assess the distribution of the talc slurry within the pleural space using cadaveric models and to determine the force required to push the talc slurry though a 14 Fr chest tube.Materials and Methods The force required to administer the talc slurry through a 14 Fr chest tube was tested using a Zwick/Roelle Z005 mechanical tester. Talc slurry distribution within the pleural cavity was assessed by direct visualisation following administration to the cadaveric models using single and multidirectional two-tube methods.Results Maximum force required to push the talc slurry though a 14 Fr chest tube was 11.36 N +/- 2.79 N. Distribution of the talc slurry within the pleural cavity was found to be poor with a single tube method. Multidirectional two-tube method of administration showed more even distribution.Conclusion The experimental multidirectional two-tube method results in wider distribution of the talc slurry within the pleural cavity and could further improve success rate of the talc pleurodesis.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicable.Funding StatementThis work was supported by the budget of School of Pharmacy and Biomolecular Sciences, as part of Year 4 Scientific Research Skills (SRS) module.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As the study involved human cadavers, the study proposal was approved by the Museum committee within Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is already included in the paper.MPEMalignant pleural effusionNNewtonFrFrenchcPCentipoise